|
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
Top US-accredited Lab Confirms Path-Away(R) Natural Active Ingredient Kills the COVID-19 Virus within Two Minutes
Sydney, Kuala Lumpur, Bluffton, SC, Oct 21, 2020 - (ACN Newswire) - A leading US lab has released results confirming Path-Away®, a plant-based active ingredient that contains no chemicals or alcohol, can kill the virus that causes COVID-19 within two minutes. Path-Away's Anti Pathogenic Aerosol Solution was tested on SARS-CoV-2 by Microbac Laboratories, Inc., accredited by the U.S. Dept of Defence (DoD) and the Environmental Laboratory Accreditation Program (ELAP).
The Microbac tests were conducted using the direct inoculation method, and follow successful tests in an approved UK laboratory (April 2020) on the efficacy of Path-Away® against the feline coronavirus, a recognised surrogate of SARS-CoV-2. Path-Away® has also proven effective against a broad spectrum of microbes including SARS and H1N1 viruses.
Holista Colltech Ltd (ASX: HCT; Holista), the Asian-based distributor, and Global Infection Control Consultants, LLC (GICC LLC), the US-based developer, said the tests confirm Path-Away® as the world's first natural and safe organic disinfectant meeting U.S. testing standards. Holista distributes Path-Away® under its own NatShield™ and Protectene™ brands. Holista and GICC LLC are also co-developing NatShield™ nasal balm with Path-Away®, to launch before the end of 2020.
Holista also has rights to Path-Away® for use in aerosolised disinfection of buildings using a high-pressure fogger. The latest test results will significanly accelerate efforts to roll out the M3 System®, also developed by GICC LLC, which can disinfect large buildings by dispensing Path-Away® through heating, ventilation and air-conditioning (HVAC) systems to treat harmful pathogens, including airborne viruses.
GICC LLC recently secured a 36-month contract with the U.S. Govt to manufacture and install 10 million units of its M3 System® in large buildings. The system measures, monitors and contains airborne (aerosol) viruses, pathogens and other biological contaminants. Holista and GICC will form a 51:49 JV to manufacture the M3 System® in Singapore. Holista is exclusivel distributor of the M3 outside the US, China and Gulf States.
Dr Arthur V Martin, the president of GICC LLC, commented: "This is the first time an organic compound has been proven to kill the virus causing COVID-19, to 99.9% within two minutes. This will speed up the formal U.S. Government process of listing on the Environmental Protection Agency's (EPA) 'List N'. EPA expects products on List N to kill SARS-CoV-2 within two minutes. This will also allow for a wider use of this all-natural disinfectant for human use. The findings by Microbac also confirmed the effects of Path-Away® on other coronaviruses, which follows research showing COVID-19 survives on surfaces longer than scientists had originally calculated."
Dr. Roscoe Moore Jr., D.V.M., Ph.D., D.Sc., Former Assistant U.S. Surgeon and member of the Global Virus Network and its International COVID-19 Taskforce, said "There is a big need for natural and human friendly disinfectants that can be used frequently and safely without long term health side effects and while being environmentally safe. The recent tests from Microbac are most welcome as the public is looking for an agent that acts specifically against COVID-19". Dr Moore also chairs Holista's Scientific Advisory Board.
Dr Rajen Manicka, Chief Executive Officer of Holista, commented: "This product will address the significant untapped global market for all-natural disinfectants that are safe to be used on hands and faces. The results from Microbac will give our customers a greater level of confidence that NatShield™ and Protectene™ can be effective on skin, surfaces and as an aerosol, against the highly contagious COVID-19 causing virus.
"We have also fielded enquiries from large organisations to disinfect buildings and facilities with sizeable human traffic. We are preparing a submission to the Australian Therapeutic Goods Administration (TGA) for approval to label Natshield™ and Protectene™ as sanitizing and disinfectant products, as well as to have Natshield approved for aerosol delivery through fogging units and through HVAC systems in Australia."
Information on Path-Away® and Microbac Test Results
How Path-Away® Works: Path-Away® attaches itself to the virus and inhibits its ability to take up amino acids - their basic building block. This forces the viruses to clump together, in the process killing themselves, almost instantly. The compound is environmentally safe with very low toxicity and does not harm humans and pets.
Test Results by Microbac: - Cells containing the SARS-CoV-2 virus were seeded in 24-well plates and 2.0 mL (millilitres) of Path-Away® was added to the (live frozen samples - thawed out) dried virus inoculum and held for the contact time of 2 minutes at 21 degrees C with 53% relative humidity (RH). For the test to be deemed successful, Path-Away® must demonstrate a ≥ 3 Log10 reduction on each test carrier in the presence or absence of cytotoxicity. - Path-Away® achieved this benchmark in each of the 24 instances (100% success rate). All controls met the criteria for a valid test and Microbac's conclusions are based on observed data. - Log Reduction stands for a 10-fold (one decimal) or 90% reduction in numbers of live bacteria. A 3-Log Reduction equates to a 99.9% reduction - greater than 1,000 time reduction in potentially harmful microorganisms. - Path-Away®, killed 99.9% (≥ 3 Log10) of the COVID-19 causing virus on a hard surface after being exposed to Path-Away®. - The full test report and process will be featured on Holista's website at https://www.holistaco.com/
About Holista Colltech Limited Holista Colltech Ltd (Holista) is a natural wellness company with Dietary supplements, Food Ingredients, Ovine collagen, and Infection Control Solutions. Holista has a global collaboration with Global Infection Control Consultants LLC to use Path-Away®, a plant-based solution that is proven to kill a broad spectrum of microbes, and the all-natural alcohol-free active ingredient used in Holista's range of disinfectant products under the NatShield™ brand.
For further information, please contact: Corporate Matters: investor@holistaco.com General Enquiries: enquiries@holistaco.com
Source: Holista CollTech Ltd Sectors: BioTech, Healthcare & Pharm
Copyright ©2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Related Press Release
| Berjaya Partners Holista to Offer Healthy Breads and Foods in Starbucks Malaysia, 7-Eleven and Other F&B Outlets | | October 12 2021 17:00 JST | | | | Malaysia Permission Granted for COVID-19 Test Kit from China for Emergency Use; Homegrown Holista Colltech Receives Initial Order for 15,000 Units for Deployment | | June 18 2021 14:00 JST | | | | Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread | | October 01 2020 15:00 JST | | | | Path-Away(R), Active Ingredient in Plant-Based, Alcohol-Free NatShield(TM) Hand Sanitiser by Holista CollTech, Tested >99.99% Effective against COVID-19 Surrogate | | April 21 2020 06:30 JST | | | | Skin Elements Enters Binding Agreement with Holista Colltech To Launch All Natural Skin-Friendly Sanitiser | | April 03 2020 17:00 JST | | | | Holista Partners GICC LLC, the U.S. Developer of Path-Away(R), to Co-Develop Nasal Sanitising Balm for Global Markets | | February 20 2020 16:00 JST | | | | Malaysians Rush for Anti-Virus Sanitiser, NatShield(TM), after Pharmacies Restock on Concerns of Spread of Deadly Disease | | February 06 2020 16:00 JST | | | | Orders for NatShield Sanitizer Spike after Outbreak of Coronavirus | | January 30 2020 16:00 JST | | | | Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Fat-Soluble Nutraceuticals | | December 13 2019 13:00 JST | | | | Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Other High-Value, Fat-Soluble Nutraceuticals | | December 12 2019 12:00 JST | | | | More Press release >> |
Latest Press Release
 Mitsubishi Motors to Celebrate "Delica Festival" with Custom Versions of Delica D:5 and Delica Mini at Tokyo Auto Salon 2026 Jan 07, 2026 08:59 JST
|  Mitsubishi Motors Launches the Xforce in Taiwan Jan 07, 2026 08:52 JST
|  Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China
Jan 07, 2026 08:43 JST
|  Alpha Growth plc: Alpha Longevity Management Ltd Expands Global Platform with Launch of Alpha Alternative Global Fund and Strengthening of Executive Leadership Team Jan 05, 2026 16:00 JST
|  The Tampere city region chose Fujitsu to deliver and develop the area's ICT services Jan 05, 2026 15:23 JST
|  Honda Newly Launches "Discover Honda" Content Curation Media Platform Dec 26, 2025 17:34 JST
|  Mazda Selected for A List in CDP Water Security for the First Time Dec 26, 2025 17:19 JST
|  Fujitsu Develops Fujitsu Kozuchi Physical AI 1.0 for Seamless Integration of Physical and Agentic AI Dec 26, 2025 14:04 JST
|  Establishment of DOCOMO Innovation Fund IV, a Corporate Venture Investment Fund Dec 26, 2025 13:53 JST
|  The General Incorporated Association Generative AI Japan Announces the Winners of the Japan Generative AI Award 2025 Dec 26, 2025 11:00 JST
|  BCQ (01963.HK) to Pay RMB 585 Million Cash Dividend, Driving Share Price and Yield Upside Dec 25, 2025 18:23 JST
|  Tohoku University and Fujitsu utilize Causal AI to discover superconductivity mechanism of promising new functional material Dec 23, 2025 14:58 JST
|  Toward an Athlete- and Planet-Friendly Hakone Ekiden: All Vehicles Provided for the 2026 Race Will Be Electrified Dec 23, 2025 03:18 JST
|  MHI Group to Accelerate Development of Digital Talent Dec 23, 2025 02:57 JST
|  MHI and EXEO Group Build and Begin Commercial Use of Japan's First GPU Servers with Two-Phase DLC Dec 23, 2025 02:20 JST
|  MHI Participates in Demonstration Testing of Vehicle-Infrastructure Integration System for Autonomous Buses in Shimotsuke City Dec 19, 2025 03:24 JST
|  NEC and emaratech Collaborate on Biometric Smart Gates Supporting UAE Airport Operations Dec 19, 2025 03:06 JST
|  Fujitsu to showcase mobility and physical AI tech at CES 2026 Dec 19, 2025 02:42 JST
|  Kirin and Fujitsu elucidate a novel gut-brain axis mechanism of citicoline for the first time worldwide through AI-based analysis and experimental validation leveraging drug discovery DX technology Dec 19, 2025 02:06 JST
|  TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Released Their Fourth Collaborative Musical Work with Sound Wellness Lab (Della): "Precious Metal Orchestra - A Musical Voyage through the Sound of Precious Metals for Christmas" now available for streaming Dec 18, 2025 22:00 JST
|
More Latest Release >>
|